WQ
FENC icon

Wealth Quarterback’s Fennec Pharmaceuticals FENC Stock Holding History

Wealth Quarterback’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$10K Hold
1,000
– – 0.01% 468
2021
Q2 		$8K Buy
+1,000
New +$6.67K ﹤0.01% 515
2020
Q2 		– Sell
-1,000
Closed -$5.94K – 328
2020
Q1 		$5.94K Sell
1,000
-5,380
-84% -$35.1K 0.01% 578
2019
Q4 		$1K Buy
+6,380
New +$34.3K ﹤0.01% 850

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wealth Quarterback's FENC Position: Q3 2021 in Review

Wealth Quarterback held its Fennec Pharmaceuticals (FENC) position steady in Q3 2021 at 1,000 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #468.

Wealth Quarterback first reported a position in FENC in Q4 2019 and has held it in 4 quarters since. 32 funds tracked by Wall St. Rank hold FENC as of Q3 2021.

  • Wealth Quarterback held 1,000 shares of Fennec Pharmaceuticals worth $10K as of Q3 2021.
  • Wealth Quarterback left its Fennec Pharmaceuticals share count unchanged in Q3 2021.
  • Fennec Pharmaceuticals made up 0.01% of Wealth Quarterback's portfolio in Q3 2021, its #468 holding.
  • Wealth Quarterback first reported a position in Fennec Pharmaceuticals in Q4 2019 and has held it in 4 quarters since.
  • 32 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.